These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6283040)

  • 21. Evidence for multiple "Kappa" binding sites by use of opioid peptides in the guinea-pig lumbo-sacral spinal cord.
    Attali B; Gouardères C; Mazarguil H; Audigier Y; Cros J
    Neuropeptides; 1982 Oct; 3(1):53-64. PubMed ID: 6296719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential ontogeny of multiple opioid receptors (mu, delta, and kappa).
    Spain JW; Roth BL; Coscia CJ
    J Neurosci; 1985 Mar; 5(3):584-8. PubMed ID: 2983043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of guanyl nucleotides and ions on kappa opioid binding.
    Mack KJ; Lee MF; Weyhenmeyer JA
    Brain Res Bull; 1985 Apr; 14(4):301-6. PubMed ID: 2988712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High affinity [3H]ethylketazocine binding: evidence for specific kappa receptors.
    Wood PL; Charleson S
    Neuropharmacology; 1982 Mar; 21(3):215-9. PubMed ID: 6122185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A monoclonal antibody capable of modulating opioid binding to rat neural membranes.
    Bidlack JM; Denton RR
    J Biol Chem; 1985 Dec; 260(29):15655-61. PubMed ID: 2999128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strain differences in opiate receptors in mouse brain.
    Reith ME; Sershen H; Vadasz C; Lajtha A
    Eur J Pharmacol; 1981 Sep; 74(4):377-80. PubMed ID: 6271560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique.
    Pfeiffer A; Herz A
    Mol Pharmacol; 1982 Mar; 21(2):266-71. PubMed ID: 6124875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Affinities of some common opioid analgesics towards four binding sites in mouse brain.
    Neil A
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):24-9. PubMed ID: 6151117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naloxone-inaccessible sigma receptor in rat central nervous system.
    Tam SW
    Proc Natl Acad Sci U S A; 1983 Nov; 80(21):6703-7. PubMed ID: 6314335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding characteristics of mu and kappa agonists in rat brain subcellular fractions.
    Monferini E; Adler MW; Simon EJ
    Life Sci; 1982 Sep 20-27; 31(12-13):1295-8. PubMed ID: 6128655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of mu, delta, and kappa opiate binding sites in rat brain and spinal cord.
    Mack KJ; Killian A; Weyhenmeyer JA
    Life Sci; 1984 Jan; 34(3):281-5. PubMed ID: 6319937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptors and secretory actions of sigma/phencyclidine agonists in anterior pituitary cells.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Dec; 121(6):2044-54. PubMed ID: 2824179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3H]Mr 2034 labels a high affinity opioid kappa-receptor not accessible to naloxazone.
    Ensinger HA
    Eur J Pharmacol; 1983 Apr; 89(1-2):143-7. PubMed ID: 6305681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J; Sánchez-Blázquez P; Lee NM
    J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of rat brain opioid receptors by cannabinoids.
    Vaysse PJ; Gardner EL; Zukin RS
    J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous ligands for sigma opioid receptors in the brain ("sigmaphin"): evidence from binding assays.
    Su TP; Weissman AD; Yeh SY
    Life Sci; 1986 Jun; 38(24):2199-210. PubMed ID: 3012236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of codeine-7,8-oxide (codeine-epoxide), as a new metabolite of codeine, with multiple opiate receptors.
    Konno F; Sato Y; Togashi K; Takayanagi I; Hirobe M
    Gen Pharmacol; 1985; 16(4):379-81. PubMed ID: 2995195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.